Kinetics of Inhibition of Glutamate Uptake by Antioestrogens

Pharmacology and Toxicology

Volumn 93, Issue 4, 2003, Pages 174-179

  Mäenpää, Hanna ^a,b   Saransaari, Pirjo ^a   Tähti, Hanna ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYASPARTIC ACID; ANTIESTROGEN; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; TAMOXIFEN; TOREMIFENE;

ANIMAL CELL; ARTICLE; BLOOD RETINA BARRIER; BREAST CANCER; CELL TRANSFORMATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HOMEOSTASIS; HUMAN; HUMAN CELL; INHIBITION KINETICS; NEUROTRANSMITTER UPTAKE; NONHUMAN; PIGMENT CELL; PRIORITY JOURNAL; RETINA DISEASE; SPECIES DIFFERENCE; SWINE;

ANIMALS; CELLS, CULTURED; DEPRESSION, CHEMICAL; ESTROGEN ANTAGONISTS; GLUTAMIC ACID; HUMANS; PIGMENT EPITHELIUM OF EYE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SPECIES SPECIFICITY; SWINE; TAMOXIFEN; TOREMIFENE;

ANIMALIA; SUS SCROFA;

EID: 0242320392     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2003.930404.x     Document Type: Article

References (41)

1. Alwitry, A. & I. Gardner: Tamoxifen maculopathy. Arch. Ophthalmol. 2002, 120, 1402.
2. Anderson, C. M., R. J. Bridges, A. R. Chamberlin, K. Shimamoto, Y. Yasuda-Kamatani & R. A. Swanson: Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal. J. Neurochem. 2001, 79, 1207-1216.
3. Arriza, J. L., W. A. Fairman, J. I. Wadiche, G. H. Murdoch, M. P. Kavanaugh & S. G. Amara: Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 1994, 14, 5559-5569.
4. Benshushan, A. & A. Brzezinski: Hormonal manipulations and breast cancer. Obstet. Gynecol. Surv. 2002, 57, 314-323.
5. Buzdar, A. U. & G. N. Hortobagyi: Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy. J. Clin. Oncol. 1998, 16, 348-353.
6. Chern, S. & R. P. Danis: Retinopathy associated with low-dose tamoxifen. Amer. J. Ophthalmol. 1993, 116, 372-373.
7. Cyr, M., C. Thibault, M. Morissette, M. Landry & P. Di: Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain. Neuropsychopharmacology 2001, 25, 242-257.
8. Danbolt, N. C.: Glutamate uptake. Prog. Neurobiol. 2001, 65, 1-105.
9. Davis, A. A., P. S. Bernstein, D. Bok, J. Turner, M. Nachtigal & R. C. Hunt: A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest. Ophthalmol. Vis. Sci. 1995, 36, 955-964.
10. Engelke, M., S. Tykhonova, K. Zorn & H. Diehl: Tamoxifen induces changes in the lipid composition of the retinal pigment epithelium cell line D407. Pharmacology Toxicology 2002, 91, 13-21.
11. Gegelashvili, G. & A. Schousboe: Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res. Bull. 1998, 45, 233-238.
12. Goodman, Y., A. J. Bruce, B. Cheng & M. P. Mattson: Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 1996, 66, 1836-1844.
13. Hard, G. C., M. J. Iatropoulos, K. Jordan, L. Radi, O. P. Kaltenberg, A. R. Imondi & G. M. Williams: Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Cancer Res. 1993, 53, 4534-4541.
14. Hardcastle, I. R., M. G. Rowlands, R. M. Grimshaw, J. Houghton & M. Jarman: Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length. J. Med. Chem. 1996, 39, 999-1004.
15. Izumi, Y., K. Shimamoto, A. M. Benz, S. B. Hammerman, J. W. Olney & C. F. Zorumski: Glutamate transporters and retinal excitotoxicity. Glia 2002, 39, 58-68.
16. Kajta, M. & W. Lason: Oestrogen effects on kainate-induced toxicity in primary cultures of rat cortical neurons. Acta Neurobiol. Exp. (Warsz.) 2000, 60, 365-369.
17. Karlsson, S., Y. Hirsimäki, E. Mäntylä, L. Nieminen, L. Kangas, P. Hirsimäki, C. J. Perry, M. Mulhern, P. Millar, J. Handa & G. M. Williams: A two-year dietary carcinogenicity study of the antiestrogen toremifene in Sprague-Dawley rats. Drug Chem. Toxicol. 1996, 19, 245-266.
18. Kontro, P. & S. S. Oja: Enzyme kinetics. In: Methods in Neurobiology. Vol. 1. Ed.: R. Lahue. Plenum Publishing Corporation, New York, 1981, pp. 265-337.
19. Mannerström, M., H. Mäenpää, T. Toimela, L. Salminen & H. Tähti: The phagocytosis of rod outer segments is inhibited by selected drugs in retinal pigment epithelial cell cultures. Pharmacology. Toxicology. 2001, 88, 27-33.
20. Mannerström, M., K. Zorn, H. Diehl, M. Engelke, T. Toimela, H. Mäenpää, A. Huhtala, H. Uusitalo, L. Salminen, P. Pappas, M. Marselos, M. Mäntylä, E. Mäntylä & H. Tähti: Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cells. Toxicol. In Vitro. 2002, 16, 193-200.
21. Massey, S. C.: Cell types using glutamate as a neurotransmitter in the vertebrate retina. In: Progress in retinal research. Eds.: N. Osborne and G. Chader. Pergamon Press, Oxford, 1990, pp. 399-426.
22. McGivan, J. D.: Rat hepatoma cells express novel transport systems for glutamine and glutamate in addition to those present in normal rat hepatocytes. Biochem. J. 1998, 330 (Pt 1), 255-260.
23. +-dependent glutamate transporter in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 1994, 35, 3589-3598.
24. Mäenpää, H., T. Toimela, P. Saransaari, L. Salminen & H. Tähti: Mechanism of tamoxifen's retinal toxicity studied in pig pigment epithelial cell cultures. ATLA 1997, 25, 297-302.
25. Mäenpää, H., M. Mannerström, T. Toimela, L. Salminen, P. Saransaari & H. Tähti: Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells. Pharmacology. Toxicology. 2002, 91, 116-122.
26. Nayfield, S. G., J. E. Karp, L. G. Ford, F. A. Dorr & B. S. Kramer: Potential role of tamoxifen in prevention of breast cancer. J. Natl Cancer Inst. 1991, 83, 1450-1459.
27. O'Brian, C. A., R. M. Liskamp, D. H. Solomon & I. B. Weinstein: Inhibition of protein kinase C by tamoxifen. Cancer Res. 1985, 45, 2462-2465.
28. Olney, J. W.: The toxic effects of glutamate and related compounds in the retina and the brain. Retina 1982, 2, 341-359.
29. Pappas, P., P. Stephanou, M. Sotiropoulou, C. Murphy, L. Salminen & M. Marselos: Effects of tamoxifen and toremifene on ALDH1 and ALDH3 in human retinal pigment epithelial cells and rat liver. Adv. Exp. Med. Biol. 1999, 463, 151-158.
30. Pavlidis, N. A., C. Petris, E. Briassoulis, G. Klouvas, C. Psilas, J. Rempapis & G. Petroutsos: Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients. Cancer 1992, 69, 2961-2964.
31. Pukkala, E., P. Kyyrönen, R. Sankila & K. Holli: Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study. Int. J. Cancer 2002, 100, 337-341.
32. Sadzuka, Y., T. Sugiyama, T. Suzuki & T. Sonobe: Enhancement of the activity of doxorubicin by inhibition of glutamate transporter. Toxicol. Lett. 2001, 123, 159-167.
33. Sahebgharani, M., S. P. Hardy, A. W. Lloyd, A. C. Hunter & M. C. Allen: Volume-activated chloride currents in HeLa cells are blocked by tamoxifen but not by a membrane impermeant quaternary analogue. Cell. Physiol. Biochem. 2001, 11, 99-104.
34. Salceda, R. & M. R. Saldana: Glutamate and taurine uptake by retinal pigment epithelium during rat development. Comp. Biochem. Physiol. [C] 1993, 104, 311-316.
35. Shy, H., L. Malaiyandi & P. S. Timiras: Protective action of 17β-estradiol and tamoxifen on glutamate toxicity in glial cells. Int. J. Devl. Neurosci. 2000, 18, 289-297.
36. Smith, S. S.: Estrogen administration increases neuronal responses to excitatory amino acids as a long-term effect. Brain Res. 1989, 503, 354-357.
37. Toimela, T., L. Salminen & H. Tähti: Effects of tamoxifen, toremifene and chloroquine on the lysosomal enzymes in cultured retinal pigment epithelial cells. Pharmacology. Toxicology. 1998, 83, 246-251.
38. Törnquist, P., A. Alm & A. Bill: Permeability of ocular vessels and transport across the blood-retinal-barrier. Eye 1990, 4 (Pt 2), 303-309.
39. Velasco, I., R. Tapia & L. Massieu: Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures. J. Neurosci. Res. 1996, 44, 551-561.
40. Wolfensberger, T.J.: Toxicology of the retinal pigment epithelium. In: The retinal pigment epithelium. Vol. 1 Eds: M. F. Marmor and T. J. Wolfensberger. Oxford University Press, New York, 1998, pp. 621-647.
41. Vorwerk, C. K., S. A. Lipton, D. Zurakowski, B. T. Hyman, B. A. Sabel & E. B. Dreyer: Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest. Ophthalmol. Vis. Sci. 1996, 37, 1618-1624.